Dr Shin Liau is a pharmacist and Research Fellow at the Centre for Medicine Use and Safety, Monash University. She leads work on optimising medication management for older adults living with frailty in community and residential aged care settings across Australia, Asia and Europe. With a strong commitment to improving medication safety and effectiveness, her current research addresses the unique challenges of appropriate prescribing by integrating deprescribing recommendations in clinical practice guidelines.

Dr. Steinman is a Professor of Medicine in the Division of Geriatrics at the University of California, San Francisco and the San Francisco VA Medical Center. A geriatrician-researcher, he cares for older adults in outpatient and inpatient settings and conducts research evaluating how older adults use medications, the problems that arise from medication overuse and misuse, and strategies for improving pharmaceutical care for older adults. He is co-principal investigator of the US Deprescribing Research Network, co-Director of the UCSF Pepper Center for Aging Research, and co-chair of the American Geriatrics Society Beers Criteria of Potentially Inappropriate Medications in Older Adults.

Sarah Hilmer (BScMed(Hons) MBBS(Hons) FRACP PhD) is the head of the department of Clinical Pharmacology and a senior staff specialist in Aged Care at Royal North Shore Hospital. She is Conjoint Professor of Geriatric Pharmacology at The University of Sydney. She is a fellow of the Australian Academy of Health and Medical Scientists (FAHMS) and was awarded a Member of the Order of Australia (AM) for her service to clinical and geriatric pharmacology in 2022. Hilmer’s translational research program in Ageing and Pharmacology at the Kolling Institute includes basic, clinical and population studies to understand the effects of medications and of deprescribing in ageing and frailty. Sarah is chair of the IUPHAR Clinical and Translational Section and also Chairs its Geriatric Pharmacology Committee.

Matt Doogue is a clinical pharmacologist passionate about applying clinical pharmacology principles to patient care. He has clinical and academic roles in clinical pharmacology and is a physician in a busy acute general medicine service. His interests include quality use of medicines, adverse drug reactions, clinical decision support, and therapeutic drug monitoring.

Danijela Gnjidic is a Professor and Head of Pharmacoepidemiology and Medication Safety, School of Pharmacy and Research Academic Director, Faculty of Medicine and Health, University of Sydney. Her research expertise is in clinical and geriatric pharmacology, deprescribing, pharmacoepidemiology, and the quality use of medicines. Danijela completed her doctoral training at the University of Sydney in 2010. She also undertook and completed a Masters of Public Health, concurrently with her PhD. Following her doctoral training, Danijela conducted post-doctoral training at the University of Eastern Finland where she furthered her geriatric pharmacology and pharmacoepidemiology research. Danijela's academic track records includes 215 publications, 3-book chapters and $20M in research funding including University of Sydney Thompson Fellowship (2023), NHMRC Dementia Leadership Fellowship (2017-21), University of Sydney Bridging Support Fellowship (2016), and NHMRC Early Career Fellowship (2012-15). Danijela was awarded the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Denis Wade Johnson & Johnson New Investigator Award in 2012, and the American Society of Clinical Pharmacology and Therapeutics (ASCPT) William B. Abrams award in Geriatric Clinical Pharmacology in 2019. Danijela is a previous Interim Deputy Associate Dean of Research, Faculty of Medicine and Health (2025), Executive Editor of the British Journal of Clinical Pharmacology (2020-24), Executive Member (2018-22), Australian Deprescribing Network (ADeN), Past President (2020-21), the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and Chair (2022-23), Geriatric Pharmacoepidemiology Special Interest Group, International Society for Pharmacoepidemiology (ISPE). Danijela was a Deputy Chair (2022-26) of the HDR Examinations Sub-Committee, University of Sydney.

Dr Emily Reeve is a Senior Research Fellow and NHMRC Emerging Leadership Fellow. She is Deputy Theme Lead of the Centre for Medicine Use and Safety at Monash University and Chair of the Australian Deprescribing Network (ADeN). Dr Reeve worked as a clinical pharmacist at the Royal Adelaide Hospital before completing a PhD at the University of South Australia.